PGDip Clinical Drug Development in London United Kingdom | Queen Mary University of London

The Postgraduate Diploma in Clinical Drug Development equips students with a multidisciplinary approach to enhance their expertise. This program caters to professionals seeking comprehensive knowledge of pharmaceutical development, offering an in-depth exploration of the intricate, interconnected processes involved in bringing drugs and biologics from discovery through to successful market launch. Our structured postgraduate curriculum in clinical drug development delivers both theoretical foundations and specialized competencies essential for careers in contract research organizations, pharmaceutical companies, or healthcare settings.

The flexible modular structure accommodates working professionals, with intensive three-day teaching sessions scheduled every four to six weeks.

Early curriculum modules focus on initial drug development phases. Students master clinical study design principles and acquire practical knowledge about early-stage development processes. The program covers ethical considerations, regulatory frameworks, and data management techniques while providing broader perspectives on drug discovery, preclinical R&D, and toxicology studies.